As of July 31, 2026, our common stock repurchase program had a total remaining authorization of approximately $1.38 billion
We have not repurchased shares under this program since 2022
Net income increased $191.1 million in the 2026 period compared to the 2025 period
no findingread · nothing bore on it
It held on this filing. No finding was written because nothing in it bore on the reason — the sentences it was read against are below.
the evidence · every sentence checkedthree sentences · whole, uncut
the claims it rests on · in our words, not the filing’s
As of July 31, 2026, our common stock repurchase program had a total remaining authorization of approximately $1.38 billion